SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-314085
Filing Date
2013-08-01
Accepted
2013-08-01 09:01:31
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d560770d10q.htm 10-Q 585461
2 EX-31.1 d560770dex311.htm EX-31.1 9157
3 EX-31.2 d560770dex312.htm EX-31.2 9338
4 EX-32.1 d560770dex321.htm EX-32.1 3490
5 EX-32.2 d560770dex322.htm EX-32.2 3672
  Complete submission text file 0001193125-13-314085.txt   6570113

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thld-20130630.xml EX-101.INS 806272
7 XBRL TAXONOMY EXTENSION SCHEMA thld-20130630.xsd EX-101.SCH 32099
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20130630_cal.xml EX-101.CAL 48104
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20130630_def.xml EX-101.DEF 105083
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20130630_lab.xml EX-101.LAB 285172
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20130630_pre.xml EX-101.PRE 204763
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 131001077
SIC: 2834 Pharmaceutical Preparations